Rising costs, high debt level and unfavorable foreign-currency movement are weighing on ZBRA's performance.
Vous n'êtes pas connecté
Explore why Medicare's cancer drug costs are skyrocketing without improving patient outcomes.
Rising costs, high debt level and unfavorable foreign-currency movement are weighing on ZBRA's performance.
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, following the expiry of its...
Cancer has long been considered a disease of old age, but doctors are now seeing more young adults diagnosed with cancers that were once rare in...
AI-powered predictions can help ICUs optimize bed management, reducing costs and improving patient care. A new model also explains its results,...
The dirty truth: Why Ghana’s beaches are drowning in plastic – and how to fix it
To explore innovative strategies and strengthen the critical nexus of quality healthcare and operational effectiveness, the Chief of the Air Staff,...
Can you include why at 76% renewables why south Australia power prices are skyrocketing
Rising student debt, fuelled by the misguided Job-ready Graduates package, is compounding young Australians’ sense of a cost-of-living crisis, and...
Rising student debt, fuelled by the misguided Job-ready Graduates package, is compounding young Australians’ sense of a cost-of-living crisis, and...
Kemi Badenoch attacks PM over rising council tax and food costs